- Home
- UAN vs ABSI Comparison
UAN vs ABSI Comparison
Compare UAN & ABSI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | UAN | ABSI |
|---|---|---|
| Founded | 2007 | 2011 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Agricultural Chemicals | Biotechnology: Pharmaceutical Preparations |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.1B | 997.8M |
| IPO Year | 2008 | 2021 |
Fundamental Metrics
Financial Performance| Metric | UAN | ABSI |
|---|---|---|
| Price | $114.29 | $11.41 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 4 |
| Target Price | N/A | ★ $6.96 |
| AVG Volume (30 Days) | 30.1K | ★ 7.9M |
| Earning Date | 04-29-2026 | 05-07-2026 |
| Dividend Yield | ★ 7.91% | N/A |
| EPS Growth | ★ 61.98 | 10.64 |
| EPS | ★ 4.72 | N/A |
| Revenue | ★ $606,038,000.00 | $4,534,000.00 |
| Revenue This Year | N/A | $215.96 |
| Revenue Next Year | N/A | $319.10 |
| P/E Ratio | $24.99 | ★ N/A |
| Revenue Growth | ★ 15.36 | N/A |
| 52 Week Low | $86.23 | $2.24 |
| 52 Week High | $139.50 | $12.06 |
Technical Indicators
Market Signals| Indicator | UAN | ABSI |
|---|---|---|
| Relative Strength Index (RSI) | 46.85 | 69.75 |
| Support Level | $107.10 | $2.80 |
| Resistance Level | $119.90 | $12.06 |
| Average True Range (ATR) | 3.19 | 1.06 |
| MACD | 1.08 | 0.08 |
| Stochastic Oscillator | 58.23 | 86.45 |
Price Performance
Historical ComparisonAbout UAN CVR Partners LP
CVR Partners LP is a manufacturer and supplier of nitrogen fertilizer products. Its principal products include Urea Ammonium Nitrate (UAN) and ammonia. The company market ammonia products to industrial and agricultural customers and UAN products to agricultural customers. The primary geographic markets for its fertilizer products are Kansas, Missouri, Nebraska, Iowa, Illinois, Colorado, and Texas. The company's product sales are heavily weighted toward UAN.
About ABSI Absci Corporation
Absci Corp is the Artificial intelligence powered synthetic biology company unlocking the potential of proteins as the next generation of therapeutics. It enables the creation of novel biologics by unifying biologic drug discovery and cell line development into one simultaneous process. Its lead product candidate, ABS-201, is an anti-prolactin receptor (PRLR) antibody engineered with an extended half-life to support a patient-friendly dosing interval.